Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Breast cancer

A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)

Dae-Won Lee, Bhumsuk Keam, Keun Seok Lee, Jin-Hee Ahn, Joohyuk Sohn, Jin Seok Ahn, Moon Hee Lee, Jee Hyun Kim, Kyung Eun Lee, Hyo Jung Kim, Si-Young Kim, Yeon Hee Park, Chan-Young Ock, Kyung-Hun Lee, Sae-Won Han, Sung-Bae Kim, Young Hyuck Im, Hyun Cheol Chung, Do-Youn Oh, Seock-Ah Im

Cancer Res Treat. 2023;55(2):523-530. Published online November 8, 2022 DOI: https://doi.org/10.4143/crt.2022.1360

Cited By 1

Gastrointestinal Cancer

Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis

Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo

Cancer Res Treat. 2021;53(3):703-713. Published online December 1, 2020 DOI: https://doi.org/10.4143/crt.2020.805

Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo

Cancer Res Treat. 2020;52(1):254-262. Published online July 9, 2019 DOI: https://doi.org/10.4143/crt.2019.190

Cited By 12

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer

Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang

Cancer Res Treat. 2018;50(4):1324-1330. Published online January 8, 2018 DOI: https://doi.org/10.4143/crt.2017.526

Cited By 19

Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen

Changhoon Yoo, Bum Jun Kim, Kyu-pyo Kim, Jae-Lyun Lee, Tae Won Kim, Baek-Yeol Ryoo, Heung-Moon Chang

Cancer Res Treat. 2017;49(3):759-765. Published online November 9, 2016 DOI: https://doi.org/10.4143/crt.2016.371

Cited By 29

Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX

Mi-Jung Kim, Sae-Won Han, Dae-Won Lee, Yongjun Cha, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Se Hyung Kim, Seock-Ah Im, Yung-Jue Bang, Tae-You Kim

Cancer Res Treat. 2016;48(3):990-997. Published online January 14, 2016 DOI: https://doi.org/10.4143/crt.2015.296

Cited By 12

Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report

Hyun Sun Woo, Kyoung Hwa Lee, Phill Hoon Yoon, Su Ji Kim, Inkeun Park, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Dong Bok Shin, Sun Jin Sym

Cancer Res Treat. 2015;47(4):949-953. Published online October 28, 2014 DOI: https://doi.org/10.4143/crt.2014.052

Cited By 6

Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer after Treatment with 5-Fluorouracil/Leucovorin and Oxaliplatin: Case Report and Literature Review

Hyung Duk Kim, Kyung Sun Ha, In Sook Woo, Yun Hwa Jung, Chi Wha Han, Tae-Jung Kim

Cancer Res Treat. 2014;46(2):204-207. Published online April 15, 2014 DOI: https://doi.org/10.4143/crt.2014.46.2.204

Cited By 14

Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil

Jae Joon Han, Sun Kyung Baek, Jae Jin Lee, Gou Young Kim, Si-Young Kim, Suk-Hwan Lee

Cancer Res Treat. 2014;46(1):55-64. Published online January 15, 2014 DOI: https://doi.org/10.4143/crt.2014.46.1.55

Cited By 16

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer

Hee Jun Lee, Hee Seung Kim, Noh Hyun Park, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Song

Cancer Res Treat. 2013;45(1):40-47. Published online March 31, 2013 DOI: https://doi.org/10.4143/crt.2013.45.1.40

Cited By 12

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang

Cancer Res Treat. 2012;44(4):235-241. Published online December 31, 2012 DOI: https://doi.org/10.4143/crt.2012.44.4.235

Cited By 22

Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer

Ji Soo Park, Jae Yun Lim, Seung Kyo Park, Min Kyung Kim, Hee Sung Ko, Sun Och Yoon, Jong Won Kim, Seung Ho Choi, Jae Yong Cho

Cancer Res Treat. 2011;43(4):236-243. Published online December 27, 2011 DOI: https://doi.org/10.4143/crt.2011.43.4.236

Cited By 15

Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer

Han Jo Kim, Jun Young Eun, Young Woo Jeon, Jina Yun, Kyoung Ha Kim, Se Hyung Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong-Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Park

Cancer Res Treat. 2011;43(3):154-159. Published online September 30, 2011 DOI: https://doi.org/10.4143/crt.2011.43.3.154

Cited By 7

A Retrospective Study of First-Line Combination Chemotherapy in Advanced Colorectal Cancer: A Korean Single-Center Experience

Soon Il Lee, Se Hoon Park, Do Hyoung Lim, Keon Woo Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Cancer Res Treat. 2011;43(2):96-101. Published online June 30, 2011 DOI: https://doi.org/10.4143/crt.2011.43.2.96

Cited By 2

Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer

Kyung Kee Baek, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun

Cancer Res Treat. 2010;42(4):185-190. Published online December 31, 2010 DOI: https://doi.org/10.4143/crt.2010.42.4.185

Cited By 29

Outcomes of Modified FOLFOX-6 as First Line Treatment in Patients with Advanced Gastric Cancer in a Single Institution; Retrospective Analysis

Han Hong Lee, Hoon Hur, Soo Hong Kim, Ae Ryung Park, Wook Kim, Hae Myung Jeon

Cancer Res Treat. 2010;42(1):18-23. Published online March 31, 2010 DOI: https://doi.org/10.4143/crt.2010.42.1.18

Cited By 12

Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric Cancer

In Sil Choi, Do-Youn Oh, Byoung-Su Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Lee

Cancer Res Treat. 2007;39(3):99-103. Published online September 30, 2007 DOI: https://doi.org/10.4143/crt.2007.39.3.99

Cited By 18

Hypersensitivity Reactions to Oxaliplatin

Kyoung-Hwan Lee, Yong Jai Park, Eun Sun Kim, Hui Jeong Hwang, Byoung Yong Shim, Hoon-Kyo Kim

Cancer Res Treat. 2006;38(4):240-241. Published online December 31, 2006 DOI: https://doi.org/10.4143/crt.2006.38.4.240

Cited By 6

Phase II Study of Oxaliplatin, 5-fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as Second Line Therapy

Duk-Joo Lee, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Myung-Ju Ahn

Cancer Res Treat. 2006;38(4):201-205. Published online December 31, 2006 DOI: https://doi.org/10.4143/crt.2006.38.4.201

Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil and Low Dose Leucovorin in Patients with Advanced Colorectal Cancer

Yoon Mi Shin, Hae Suk Han, Seong Woo Lim, Byung Chul Kim, Kyung Suck Cheoi, Young Ook Eum, Seung Taek Kim, Ki Hyeong Lee

Cancer Res Treat. 2005;37(5):284-289. Published online October 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.5.284

Cited By 3

Oxaliplatin with Biweekly Low Dose Leucovorin and Bolus and Continuous Infusion of 5-fluorouracil (Modified FOLFOX 4) as a Salvage Therapy for Patients with Advanced Gastric Cancer

Sung-Hwan Suh, Hyuk-Chan Kwon, Ji-Hoon Jo, Young-Rak Cho, Bong-Gun Seo, Dong-Mee Lee, Sung-Hyun Kim, Jae-Seok Kim, Hyo-Jin Kim

Cancer Res Treat. 2005;37(5):279-283. Published online October 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.5.279

Cited By 11

Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer

Byoung Yong Shim, Kang Moon Lee, Hyeon-Min Cho, Hyun Jin Kim, Hong Joo Cho, Jinmo Yang, Jun-Gi Kim, Hoon-Kyo Kim

Cancer Res Treat. 2005;37(4):212-215. Published online August 31, 2005 DOI: https://doi.org/10.4143/crt.2005.37.4.212

Cited By 4

The Efficacy of a Modified Chronomodulated Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin in Advanced Colorectal Cancer (Preliminary Data)

Ji Young Park, Si-Young Kim, Jae Jin Lee, Hwi Joong Yoon, Kyung Sam Cho

Cancer Res Treat. 2004;36(3):199-204. Published online June 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.3.199

Cited By 1

Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer

Hyuk-Chan Kwon, Kyoung Tae Kim, Shin Ae Lee, Jong-Sung Park, Sung-Hyun Kim, Jae-Seok Kim, Hyo Jin Kim

Cancer Res Treat. 2004;36(2):115-120. Published online April 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.2.115

Cited By 6

Combination Chemotherapy of Oxaliplatin and Capecitabine in Patients with Metastatic Colorectal Cancer: a Pilot Study

Myung Ju Ahn, Ho Suck Oh, Jung Hye Choi, Young Yeul Lee, In Soon Kim, Il Young Choi, Oh Young Lee, Heung Woo Lee

Cancer Res Treat. 2003;35(5):407-410. Published online October 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.5.407

Cited By 2

Antitumor Activity of Oxaliplatin, 5-FU and Paclitaxel Given Alone or in Combination with ZD1839 in Human Gastric Carcinoma Cells in vitro

Ji Hyun Jang, Sang Hak Lee, Jin Hyoung Kang, Hee Sik Sun, Kazuto Nishio, Nagahiro Saijo, Hyo Jeong Kuh

Cancer Res Treat. 2002;34(5):372-381. Published online October 31, 2002 DOI: https://doi.org/10.4143/crt.2002.34.5.372

Cited By 1

A Phase II Study of Oxaliplatin Combined with 5-Fluorouracil and Leucovorin (Mayo Clinic Regimen) in 5-Fluorouracil Refractory Colorectal Cancer

Yee Zee Bae, Jae Hyuk Jung, Chang Hoon Moon, Seong Hyun Kim, Hyuk Chan Kwon, Jae Seok Kim, Hyo Jin Kim

Cancer Res Treat. 2002;34(3):218-222. Published online June 30, 2002 DOI: https://doi.org/10.4143/crt.2002.34.3.218

Cited By 4

Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5-Fluorouracil-Pretreated Patients with Metastatic Colorectal Cancer

Soo Mee Bang, Eun Kyung Cho, Jae Hwan Oh, Heung Moon Chang, Jin Seok Ahn, Jung Ae Lee, Young Iee Park, Myung Jue Ahn, Young Suk Park, Dong Bok Shin, Jae Hoon Lee

Cancer Res Treat. 2001;33(5):414-419. Published online October 31, 2001 DOI: https://doi.org/10.4143/crt.2001.33.5.414

Cited By 1

A Phase II Study of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5- Fluorouracil-Pretreated Metastatic Colorectal Cancer

Keun Seok Lee, Won Sup Lee, Hark Kyun Kim, Joo Young Jeong, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim

J Korean Cancer Assoc. 2001;33(2):99-105.